pubmed-article:15138714 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15138714 | lifeskim:mentions | umls-concept:C0032854 | lld:lifeskim |
pubmed-article:15138714 | lifeskim:mentions | umls-concept:C0334634 | lld:lifeskim |
pubmed-article:15138714 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
pubmed-article:15138714 | lifeskim:mentions | umls-concept:C0243095 | lld:lifeskim |
pubmed-article:15138714 | lifeskim:mentions | umls-concept:C1413172 | lld:lifeskim |
pubmed-article:15138714 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
pubmed-article:15138714 | lifeskim:mentions | umls-concept:C2599665 | lld:lifeskim |
pubmed-article:15138714 | lifeskim:mentions | umls-concept:C1561558 | lld:lifeskim |
pubmed-article:15138714 | lifeskim:mentions | umls-concept:C0522498 | lld:lifeskim |
pubmed-article:15138714 | pubmed:issue | 9 | lld:pubmed |
pubmed-article:15138714 | pubmed:dateCreated | 2004-9-27 | lld:pubmed |
pubmed-article:15138714 | pubmed:abstractText | A patient with mantle cell lymphoma (MCL) of the pleomorphic blastoid subtype is reported. The disease was clinically aggressive and refractory to chemotherapy, and the patient survived only 2 months. Cytogenetically, a t(11;19;14)(q13;q13;q32) was found. Fluorescent in situ hybridization (FISH) and molecular analyses demonstrated involvement of the BCL1/CCND1 locus in a three-way translocation. In addition, subclonal abnormalities of the region 8q24 manifested either as a t(8;22)(q24;q11)/CMYC rearrangement or trisomy 8 were identified. The pathogenetic impact of this very uncommon association of BCL1/CCND1 and CMYC rearrangements in MCL is discussed and the literature is reviewed. | lld:pubmed |
pubmed-article:15138714 | pubmed:language | eng | lld:pubmed |
pubmed-article:15138714 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15138714 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15138714 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15138714 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15138714 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15138714 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15138714 | pubmed:month | Sep | lld:pubmed |
pubmed-article:15138714 | pubmed:issn | 0939-5555 | lld:pubmed |
pubmed-article:15138714 | pubmed:author | pubmed-author:HagemeijerAA | lld:pubmed |
pubmed-article:15138714 | pubmed:author | pubmed-author:FerrantAA | lld:pubmed |
pubmed-article:15138714 | pubmed:author | pubmed-author:WlodarskaII | lld:pubmed |
pubmed-article:15138714 | pubmed:author | pubmed-author:MichauxLL | lld:pubmed |
pubmed-article:15138714 | pubmed:author | pubmed-author:StulMM | lld:pubmed |
pubmed-article:15138714 | pubmed:author | pubmed-author:DeneysVV | lld:pubmed |
pubmed-article:15138714 | pubmed:author | pubmed-author:TheateII | lld:pubmed |
pubmed-article:15138714 | pubmed:author | pubmed-author:ScheiffJ-MJM | lld:pubmed |
pubmed-article:15138714 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15138714 | pubmed:volume | 83 | lld:pubmed |
pubmed-article:15138714 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15138714 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15138714 | pubmed:pagination | 578-83 | lld:pubmed |
pubmed-article:15138714 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:15138714 | pubmed:meshHeading | pubmed-meshheading:15138714... | lld:pubmed |
pubmed-article:15138714 | pubmed:meshHeading | pubmed-meshheading:15138714... | lld:pubmed |
pubmed-article:15138714 | pubmed:meshHeading | pubmed-meshheading:15138714... | lld:pubmed |
pubmed-article:15138714 | pubmed:meshHeading | pubmed-meshheading:15138714... | lld:pubmed |
pubmed-article:15138714 | pubmed:meshHeading | pubmed-meshheading:15138714... | lld:pubmed |
pubmed-article:15138714 | pubmed:meshHeading | pubmed-meshheading:15138714... | lld:pubmed |
pubmed-article:15138714 | pubmed:meshHeading | pubmed-meshheading:15138714... | lld:pubmed |
pubmed-article:15138714 | pubmed:meshHeading | pubmed-meshheading:15138714... | lld:pubmed |
pubmed-article:15138714 | pubmed:meshHeading | pubmed-meshheading:15138714... | lld:pubmed |
pubmed-article:15138714 | pubmed:meshHeading | pubmed-meshheading:15138714... | lld:pubmed |
pubmed-article:15138714 | pubmed:meshHeading | pubmed-meshheading:15138714... | lld:pubmed |
pubmed-article:15138714 | pubmed:meshHeading | pubmed-meshheading:15138714... | lld:pubmed |
pubmed-article:15138714 | pubmed:meshHeading | pubmed-meshheading:15138714... | lld:pubmed |
pubmed-article:15138714 | pubmed:meshHeading | pubmed-meshheading:15138714... | lld:pubmed |
pubmed-article:15138714 | pubmed:meshHeading | pubmed-meshheading:15138714... | lld:pubmed |
pubmed-article:15138714 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:15138714 | pubmed:articleTitle | Coexistence of BCL1/CCND1 and CMYC aberrations in blastoid mantle cell lymphoma: a rare finding associated with very poor outcome. | lld:pubmed |
pubmed-article:15138714 | pubmed:affiliation | Department of Hematology, Clinical Biology and Pathology, Cliniques universitaires UCL St Luc, Brussels, Belgium. | lld:pubmed |
pubmed-article:15138714 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15138714 | pubmed:publicationType | Case Reports | lld:pubmed |
pubmed-article:15138714 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
entrez-gene:595 | entrezgene:pubmed | pubmed-article:15138714 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:15138714 | lld:entrezgene |